Baxter International Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名72/208位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价24.20。中期看,股价处于下降通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
Baxter International Inc评分
相关信息
行业排名
72 / 208
全市场排名
172 / 4582
所属行业
医疗设备与耗材
压力支撑
由于公司未披露,未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
18
位分析师
持有
评级
24.201
目标均价
+33.26%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
Baxter International Inc亮点
亮点风险
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
公司代码BAX
公司Baxter International Inc
CEOHider (Andrew P)
网址https://www.baxter.com/
常见问题
Baxter International Inc(BAX)的当前股价是多少?
Baxter International Inc(BAX)的当前股价是 18.960。
Baxter International Inc的股票代码是什么?
Baxter International Inc的股票代码是BAX。
Baxter International Inc股票的52周最高点是多少?
Baxter International Inc股票的52周最高点是37.740。
Baxter International Inc股票的52周最低点是多少?
Baxter International Inc股票的52周最低点是17.400。
Baxter International Inc的市值是多少?
Baxter International Inc的市值是9.74B。
Baxter International Inc的净利润是多少?
Baxter International Inc的净利润为-649.00M。
现在Baxter International Inc(BAX)的股票是买入、持有还是卖出?
根据分析师评级,Baxter International Inc(BAX)的总体评级为持有,目标价格为24.201。
Baxter International Inc(BAX)股票的每股收益(EPS TTM)是多少
Baxter International Inc(BAX)股票的每股收益(EPS TTM)是-0.670。